220 related articles for article (PubMed ID: 36967793)
1. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
[TBL] [Abstract][Full Text] [Related]
2. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A; Daly AF
Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
[TBL] [Abstract][Full Text] [Related]
3. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
Yarman S; Tuncer FN; Serbest E
Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
5. Familial pituitary tumors.
Alband N; Korbonits M
Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1 (MEN1).
Thakker RV
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
[TBL] [Abstract][Full Text] [Related]
8. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
[TBL] [Abstract][Full Text] [Related]
9. Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.
Nunes VS; Souza GL; Perone D; Conde SJ; Nogueira CR
Pituitary; 2014 Feb; 17(1):30-7. PubMed ID: 23334809
[TBL] [Abstract][Full Text] [Related]
10. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
13. [Multiple endocrine neoplasia type 1: about a case].
Anguezomo G; El Mghari G; El Ansari N
Pan Afr Med J; 2019; 33():238. PubMed ID: 31692695
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
16. Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I.
Chico A; Gallart L; Martín-Campos JM; Catasús L; Mayoral C; Mato E; Tortosa F; Bernà L; Rodríguez-Espinosa J; Blanco-Vaca F; Matías-Guiu X; de Leiva A; Mauricio D
Endocr Pract; 2000; 6(1):13-9. PubMed ID: 11419921
[TBL] [Abstract][Full Text] [Related]
17. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.
Farrell WE; Azevedo MF; Batista DL; Smith A; Bourdeau I; Horvath A; Boguszewski M; Quezado M; Stratakis CA
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1905-14. PubMed ID: 21917868
[TBL] [Abstract][Full Text] [Related]
18. Mixed gangliocytoma-pituitary adenoma in MEN1 syndrome: A case report and literature review.
Martin EC; Bitner BF; Perez-Rosendahl M; Kuan EC; Linskey ME
Neuropathology; 2022 Apr; 42(2):155-159. PubMed ID: 35137463
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
[TBL] [Abstract][Full Text] [Related]
20. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
